Real-world study assesses first-line anti-PD-1, IFN-α1b, and anlotinib for advanced melanoma
A real-world study of patients with unresectable advanced melanoma in China has found that adding the cancer drug anlotinib to ...
A real-world study of patients with unresectable advanced melanoma in China has found that adding the cancer drug anlotinib to ...
WASHINGTON — A combination of two immunotherapy drugs produced substantially higher rates of tumor eradication when added to chemotherapy before ...
A new viral-science report highlights fresh evidence that directly targeting oncogenic KRAS can prime the immune system to fight pancreatic ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine